Podcasts

Semaglutide vs. Tirzepatide: Are We Closing the Gap?
How the STEP-UP trial came to life, Â and what made the 7.2mg dose possible
What the data actually says about...

Clinical vs Anthropometric Obesity
Takeaways
- The study examines the overlap between clinical and anthropometric obesity.
- Anthropometric measures include waist circumference, waist-to-hip ratio, and...

GLP-1 meds and macular degeneration
Learn what age-related macular degeneration (AMD) is
What causes AMD
The types of AMD
The update on NAION – listen...

Menopause, MHT, and GLP-1 medicines
- Menopausal hormonal therapy should not be a blanket recommendation for everyone going through menopause
- Weight management in women is...

The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass
- Dr. Grant Tinsley joins the discussion as the body composition expert.
- Myostatin is a key regulator of muscle growth. ...

Current State of Nutrition Research and MAHA
Takeaways:
- The MAHA report aims to address public health issues but lacks actionable policies.
- Historical context is crucial for...

Joy Prescriptions
Click to read Joy Prescriptions
Drs. Karl and Spencer talk to Dr. Tiffany Moon all about Joy Prescriptions....

Zepbound versus Wegovy
- Tirzepatide is more effective for weight loss than semaglutide.
- Cost-effectiveness is crucial in prescribing weight loss medications.
- Patients with...

Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH).
Takeaways
- MASH is a significant obesity-related complication.
- Semaglutide shows promise in treating MASH.
- Weight loss is crucial for improving...

Top 5 Women’s Fitness Myths
Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in...

GLP-1 and metabolism and depression
Drs. Karl and Spencer discuss a new study looking at tirzepatide and metabolic rate. They also discuss a patient case...

Do GLP-1 meds cause more fat cells?
Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells.
Learn about if and how GLP-1...

Future of medicine – Direct Care
Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care – the future of medicine.
Learn...

Tirzepatide and Muscle Loss with Dr. Grant Tinsley
Drs. Karl and Spencer discuss with Dr. Grant Tinsley all about the new analysis of how much "lean mass" is...

The Super Bowl Hims and Hers Ad
Drs. Karl and Spencer discuss how bad the Hims and Hers ad was.
From an outside perspective, the ad may...

NAD and NMN with Dr. Charles Brenner
Drs. Karl and Spencer chat with NMN and NAD expert Dr. Charles Brenner all about these supposed longevity supplements.
Learn...

The 60 Minutes Obesity Doctor – Dr. Fatima Cody Stanford
Drs. Karl and Spencer chat with Dr. Fatima Cody Stanford all about obesity, genetics, and her appearance on 60 minutes.
...
New Obesity Definition and Higher Wegovy Dose
Drs. Karl and Spencer chat about the new Lancet Commission's report on Clinical Obesity along with the new study on...

The Ozempic Revolution – with Dr. Sowa
Drs. Karl and Spencer chat with Dr. Sowa about her book The Ozempic Revolution.
Learn:
Why she wrote the book.
...
Microdosing GLP-1 and Cagrisema headlines
Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line...

Changing your workouts based on your menstrual cycle
Drs. Karl and Spencer chat with Dr. Lauren Colenso-Semple all about how the menstrual cycle and how it should affect...

Zepbound vs Wegovy trial and compounded GLP-1s
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight...

Types of Diabetes, CGMs, and More
Drs. Karl and Spencer chat with Dr. Shivani Misra, a metabolic specialist physician researcher from the UK, all about the...

A new way of delivering healthcare – Direct Primary Care
Drs. Karl and Spencer chat with AtlasMD – Dr. Josh Umbehr all about making healthcare cheaper using direct primary care.
...
